# Morrison Foerster

represented a party in the 2026 $2.25 billion global patent settlement between Moderna and Arbutus/Genevant over mRNA lipid-nanoparticle delivery technology, confirmed via the firm's own news page and independent legal-press coverage of the settlement — a genuine, high-value, on-topic biotech patent dispute resolution.

Source: https://en.bioecon.ru/companies/morrison-foerster/
Updated: 2026-08-21

- Country: United States

## Technologies

- [Bio-arbitration](https://en.bioecon.ru/technology/bio-arbitration/)